Dr. Bill Guo is the Chairman and founder of Venturepharm Group, a leading full service plus pharmaceutical company in Asia, and led its two flag ship Venturepharm lab to become the first CRO company listed in HK and CBI group, the first Chinese company made acquisition in NSDAQ. he has spent over 9 years global pharmaceutical experiences from researcher to senior executive e.g. Johnson & Johnson, Novapharm and Venturpharm Canada in North American. 9 years of entrepreneurs experiences in China. After obtained the medical degree in China, Bill went to Canada to pursue his Master and Ph.D Studies with respectively, pharmacokinetics and physical pharmaceuticals from the University of Toronto, MBA programs from Herriot Watt University and Executive education from Judge Business School, University of Cambridge UK Fortune magazine recognized him as one of the most potential entrepreneurs in China. He was also recipient of various rewards: 2005 National Hero awarded by the state council of China; One of the Ten best management elites in China in 2004, one of the ten most influential individual in economic field of China, 2005. Distinguished entrepreneur awarded from oversea by government of China, 2005. Sole winner of Youth Chinese Entrepreneur Award organized by Asia Business Week in 2003. 2005 Entrepreneurs and innovation by BCC (British Chamber of Commerce);Specialties: Venturepharm group is an Asia based, life science leader with principal activities in an most affordable world-class innovative full service plus model from venture capital, merchant banking, CRO, CMO, CSO, compound partnering to royalty sharing. Venturepharm engages in strategic licensing of therapeutic compound pipelines, and markets projects to China, an emerging global top five market. Two of the flagships from the group are public trade companies:-